Brief: Abeona Therapeutics And Lurie Children's Open First Center For Zevaskyntm Gene Therapy
14/05/2025 12:46
May 14 (Reuters) - Abeona Therapeutics Inc ABEO.O: ABEONA THERAPEUTICS® AND LURIE CHILDREN'S OPEN FIRST CENTER FOR ZEVASKYNTM GENE THERAPY TO TREAT WOUNDS IN PAINFUL SKIN DISORDER ABEONA THERAPEUTICS INC: TREATMENTS ARE EXPECTED TO BEGIN IN Q3 OF 2025 Source text: ID:nGNX2ybsfG Further company coverage: ABEO.O
Recent news on Abeona Therapeutics
See all newsBrief: Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Ultragenyx rises after FDA nod for rare disorder drug
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce
U.S. STOCKS ON THE MOVE-Cerebras, Madison Square Garden Sports